Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) EBITDA (2016 - 2025)

Historic EBITDA for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $99.4 million.

  • Qiagen's EBITDA fell 1650.66% to $99.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $465.9 million, marking a year-over-year increase of 37676.41%. This contributed to the annual value of $465.9 million for FY2025, which is 14620.71% up from last year.
  • According to the latest figures from Q4 2025, Qiagen's EBITDA is $99.4 million, which was down 1650.66% from $129.2 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's EBITDA ranged from a high of $207.1 million in Q1 2022 and a low of -$228.4 million during Q2 2024
  • For the 5-year period, Qiagen's EBITDA averaged around $105.9 million, with its median value being $113.7 million (2024).
  • As far as peak fluctuations go, Qiagen's EBITDA tumbled by 31666.76% in 2024, and later soared by 15336.35% in 2025.
  • Over the past 5 years, Qiagen's EBITDA (Quarter) stood at $173.1 million in 2021, then crashed by 39.6% to $104.6 million in 2022, then rose by 5.78% to $110.6 million in 2023, then grew by 7.67% to $119.1 million in 2024, then dropped by 16.51% to $99.4 million in 2025.
  • Its EBITDA was $99.4 million in Q4 2025, compared to $129.2 million in Q3 2025 and $121.9 million in Q2 2025.